KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Capital Expenditures (2016 - 2025)

Supernus Pharmaceuticals has reported Capital Expenditures over the past 14 years, most recently at $427000.0 for Q4 2025.

  • Quarterly Capital Expenditures rose 100.47% to $427000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 84.55% year-over-year, with the annual reading at $1.3 million for FY2025, 84.55% up from the prior year.
  • Capital Expenditures was $427000.0 for Q4 2025 at Supernus Pharmaceuticals, up from $129000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $549000.0 in Q1 2022 and troughed at -$168000.0 in Q4 2022.
  • The 4-year median for Capital Expenditures is $200000.0 (2024), against an average of $201733.3.
  • The largest YoY upside for Capital Expenditures was 691.67% in 2024 against a maximum downside of 59.75% in 2024.
  • A 4-year view of Capital Expenditures shows it stood at -$168000.0 in 2022, then surged by 78.57% to -$36000.0 in 2023, then skyrocketed by 691.67% to $213000.0 in 2024, then soared by 100.47% to $427000.0 in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Capital Expenditures are $427000.0 (Q4 2025), $129000.0 (Q3 2025), and $455000.0 (Q2 2025).